Physician

Anand S. Kenia, M.D.

According to 2025 Medicare claims, Anand Kenia, M.D. (NPI: 1891990719) practices cardiac electrophysiology in the Dalton, GA market, with the plurality of this provider's patient population coming from Whitfield, GA. This provider's primary affiliated billing organization is HAMILTON PHYSICIAN GROUP INC (NPI: 1235455569; TIN: 581519911) and primary practice location at 30720-2529. Kenia is affiliated with the eBrightHealth ACO (ACO ID: A3053), WellStar Clinical Partners Medicare ACO, LLC (ACO ID: A4803), and Aledade 154 FL GA MSSP Enhanced (ACO ID: A5357), participating under the MSSP model.

Kenia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,171 traditional Medicare patients, billed 2,820 HCPCS/CPT codes, and received $128,445 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,756 prescription claims across 505 beneficiaries totaling $769,249 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 78 claims. Open Payments data shows 136 records totaling $28,788. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $224,350 and ending at $128,445. Concurrently, Part D prescription costs have risen steadily, from $60,366 to $769,249. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $22,294 to $1,722.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,392	3,982	$224,350
2016	2,060	3,266	$185,414
2017	1,216	1,997	$139,850
2018	1,312	2,795	$175,381
2019	1,731	3,979	$233,484
2020	1,571	4,051	$227,199
2021	1,532	4,194	$238,460
2022	1,192	3,522	$181,707
2023	1,239	3,630	$188,100
2024	1,171	2,820	$128,445

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	152	514	$60,366
2016	238	1,259	$190,639
2017	269	1,499	$255,599
2018	302	1,070	$155,498
2019	357	1,484	$290,200
2020	422	2,100	$488,065
2021	498	2,505	$650,621
2022	525	2,366	$720,355
2023	595	2,978	$1,146,849
2024	505	1,756	$769,249

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	82	$2,041
2017	N/R	78	$1,991
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	117	117	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	128	146	$74
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	189	264	$18
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	251	319	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	557	790	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	332	20,252	$395,021
Xarelto	Rivaroxaban	41	3,510	$64,147
Ozempic	Semaglutide	33	1,442	$42,109
Multaq	Dronedarone Hcl	14	1,020	$25,000
Jardiance	Empagliflozin	15	1,349	$23,632

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	136	$28,788	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anand S. Kenia, M.D.?

Tedicare shows public-source Medicare data for Anand S. Kenia, M.D. (NPI 1891990719), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anand S. Kenia, M.D. have ACO affiliation data?

Anand S. Kenia, M.D. is shown with ACO affiliation data for eBrightHealth ACO (MSSP, ACO ID A3053), WellStar Clinical Partners Medicare ACO, LLC (MSSP, ACO ID A4803), and Aledade 154 FL GA MSSP Enhanced (MSSP, ACO ID A5357).

What billing organization is linked to Anand S. Kenia, M.D.?

Anand S. Kenia, M.D. is linked to HAMILTON PHYSICIAN GROUP INC (billing NPI 1235455569) in the available physician profile data.

Does Anand S. Kenia, M.D. have Open Payments data?

Anand S. Kenia, M.D. has 136 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.